Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2021-09-15
DICEDice Therapeutics, Inc.Scopa James PaulDirP - Purchase$17.00+6,00055,841+12%+$102,000
D
2021-09-14
ALZNAlzamend Neuro, Inc.Ault Milton C III10%P - Purchase$2.70+5,00031,870,3880%+$13,492
2021-09-14
INDPIndaptus Therapeutics, Inc.Meckler Jeffrey ACEO, DirP - Purchase$7.00+12,00014,460+488%+$84,000
M
2021-09-14
ORICOric Pharmaceuticals, Inc.Heyman Richard A.DirS - Sale$25.04-1,388228,772-1%-$34,760
M
2021-09-14
ORICOric Pharmaceuticals, Inc.Chacko JacobPres, CEOS - Sale$25.05-8,1562,652-75%-$204,335
M
2021-09-14
BGNEBeigene, Ltd.Oyler JohnCEOS - Sale$82.04-411,83849,551,731-1%-$33,788,320
M
2021-09-14
RAPTRapt Therapeutics, Inc.Column Group Ii, LP10%S - Sale$37.01-181,2113,146,989-5%-$6,707,218
D
2021-09-14
AUPHAurinia Pharmaceuticals Inc.Martin Michael RobertChief Business OfficerS - Sale+OE$21.78-44,000397,722-10%-$958,220
D
2021-09-15
SDGRSchrodinger, Inc.Akinsanya KarenSee RemarksS - Sale+OE$61.13-1,3940-100%-$85,215
M
2021-09-14
MYOVMyovant Sciences Ltd.Sumitomo Chemical Co., Ltd.10%P - Purchase$22.03+161,16449,628,5220%+$3,551,175
D
2021-09-16
UTHRUnited Therapeutics CorpMahon Paul AEVP, GCS - Sale+OE$204.08-6,00036,369-14%-$1,224,467
D
2021-09-14
OPNTOpiant Pharmaceuticals, Inc.Thomas Thomas T.DirS - Sale+OE$19.37-1,5718,107-16%-$30,431
D
2021-09-14
GBIOGeneration Bio Co.Stanton MatthewCHIEF SCIENTIFIC OFFICERS - Sale+OE$28.07-4,500198,154-2%-$126,315
2021-09-16
OPNTOpiant Pharmaceuticals, Inc.Crystal RogerCEO, 10%P - Purchase$23.44+1005,100+2%+$2,344
2021-09-14
CMRXChimerix IncCantex Pharmaceuticals, Inc.10%S - Sale$5.75-6,500,0003,500,000-65%-$37,375,000
D
2021-09-15
QUREUniqure N.V.Kuta Alexander Edward IIIEVP, OperationsS - Sale+OE$36.32-6,00068,871-8%-$217,920
2021-09-16
TFFPTff Pharmaceuticals, Inc.Mattes Glenn R.Pres, CEOP - Purchase$7.10+10,00027,000+59%+$71,000
2021-09-16
TFFPTff Pharmaceuticals, Inc.Coleman Kirk AllenCFO, Secretary, TreasurerP - Purchase$7.30+1,0002,000+100%+$7,300
2021-09-14
NBRVNabriva Therapeutics PlcSchroeder Theodore RCEOP - Purchase$1.13+50,000226,875+28%+$56,500
M
2021-09-13
SPROSpero Therapeutics, Inc.Aquilo Capital Management, LLC10%P - Purchase$18.56+46,3664,429,145+1%+$860,547
D
2021-09-15
CYRXCryoport, Inc.Berman Richard JDirS - Sale+OE$64.00-25,000100,000-20%-$1,599,875
D
2021-09-13
ANNXAnnexon, Inc.Yednock TedEVP, Chief Scientific OfficerS - Sale+OE$20.00-16,1900-100%-$323,860
D
2021-09-13
ANNXAnnexon, Inc.Lew JenniferEVP, CFOS - Sale+OE$20.01-3,5002,000-64%-$70,034
2021-09-13
BGNEBeigene, Ltd.Huang JaneCMO, HematologyS - Sale$358.14-12,901145,235-8%-$4,620,390
M
2021-09-13
CORTCorcept Therapeutics IncRobb Gary CharlesChief Business OfficerS - Sale$20.54-55,000101,540-35%-$1,129,923
2021-09-13
IMRXImmuneering CorpFeinberg PeterDirP - Purchase$21.50+6,099984,647+1%+$131,114
2021-09-15
DMACDiamedica Therapeutics Inc.Alcorn Harry W JrSVP, Clinical OperationsP - Purchase$3.80+15,00043,981+52%+$56,960
2021-09-14
ANGNAngion Biomedica Corp.Rhodes Jennifer JSee RemarksS - Sale$10.64-43031,713-1%-$4,575
DM
2021-09-13
SNDXSyndax Pharmaceuticals IncMetzger Michael APres, COOS - Sale+OE$19.12-61,00017,659-78%-$1,166,033
D
2021-09-13
BPMCBlueprint Medicines CorpHurley ArielPrincipal Accounting OfficerS - Sale+OE$100.00-60010,097-6%-$60,000
D
2021-09-13
BPMCBlueprint Medicines CorpHaviland KateCOOS - Sale+OE$99.94-1,00053,948-2%-$99,936
2021-09-15
ATXIAvenue Therapeutics, Inc.Vazzano Joseph WalterCFOS - Sale$1.62-7,16065,252-10%-$11,599
DM
2021-09-13
REGNRegeneron Pharmaceuticals, Inc.Zoghbi Huda YDirS - Sale+OE$650.00-1,000891-53%-$650,002
2021-09-14
OPNTOpiant Pharmaceuticals, Inc.O'Toole David DCFOP - Purchase$19.12+20024,015+1%+$3,824
2021-09-13
OPNTOpiant Pharmaceuticals, Inc.Collard Craig ADirP - Purchase$18.13+2,50017,283+17%+$45,325
2021-09-14
NMTR9 Meters Biopharma, Inc.Sitar Edward JCFOP - Purchase$1.22+15,000194,338+8%+$18,300
2021-09-13
OCUPOcuphire Pharma, Inc.Pepose JayDirP - Purchase$4.75+12,63114,744+598%+$59,997
2021-09-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.46+100,000226,367,8220%+$346,443
M
2021-09-13
NGMNgm Biopharmaceuticals IncChen Jin-LongChief Scientific OfficerS - Sale$25.84-30,000929,449-3%-$775,306
D
2021-09-13
HRMYHarmony Biosciences Holdings, Inc.Jacobs John CPres, CEOS - Sale+OE$35.93-25,0000-100%-$898,263
DM
2021-09-10
AUPHAurinia Pharmaceuticals Inc.Martin Michael RobertChief Business OfficerS - Sale+OE$20.89-115,000353,722-25%-$2,402,217
2021-09-10
PGENPrecigen, Inc.Ares Trading S.A.10%S - Sale$6.29-4,58421,098,7060%-$28,814
M
2021-09-10
RAPTRapt Therapeutics, Inc.Column Group Ii, LP10%S - Sale$35.22-36,0553,183,459-1%-$1,269,950
2021-09-13
ARWRArrowhead Pharmaceuticals, Inc.Olukotun Adeoye YDirS - Sale$63.76-5,0009,000-36%-$318,800
M
2021-09-10
AUPHAurinia Pharmaceuticals Inc.Huizinga Robert BindertEVP of ResearchS - Sale$21.15-32,500106,092-23%-$687,325
D
2021-09-10
AUPHAurinia Pharmaceuticals Inc.Solomons NeilChief Medical OfficerS - Sale+OE$19.84-150,000137,299-52%-$2,976,000
D
2021-09-14
ATNXAthenex, Inc.Wu JinnDirP - Purchase$3.22+50,000403,208+14%+$161,000
D
2021-09-13
SDGRSchrodinger, Inc.Abel Robert LorneSee RemarksS - Sale+OE$61.75-15,6020-100%-$963,435
2021-09-13
IMRXImmuneering CorpZeskind Benjamin J.Pres, CEO, 10%P - Purchase$22.87+2,0833,147,2790%+$47,632
M
2021-09-13
APLTApplied Therapeutics Inc.Shendelman ShoshanaPres, CEO, 10%P - Purchase$14.50+10,0014,694,7770%+$145,038
2021-09-10
TCDATricida, Inc.Coufal Sandra IDir, 10%S - Sale$4.23-5,0006,572,2650%-$21,150
D
2021-09-10
GBIOGeneration Bio Co.Stanton MatthewCHIEF SCIENTIFIC OFFICERS - Sale+OE$25.97-3,000198,154-1%-$77,910
2021-09-14
OPNTOpiant Pharmaceuticals, Inc.Gorman BrianGeneral CounselP - Purchase$19.04+1,31221,586+6%+$24,980
M
2021-09-10
ORICOric Pharmaceuticals, Inc.Chacko JacobPres, CEOS - Sale$25.05-5,74310,808-35%-$143,872
2021-09-14
CLRBCellectar Biosciences, Inc.Swirsky Douglas JDirP - Purchase$1.04+25,00025,000New+$26,000
2021-09-14
TBIOTranslate Bio, Inc.Sanofi10%P - Purchase$38.00+71,983,59775,668,031>999%+$2,147,483,647
2021-09-13
IMNMImmunome Inc.Rapp MichaelDirP - Purchase$19.96+25,9621,008,608+3%+$518,202
M
2021-09-09
PMVPPmv Pharmaceuticals, Inc.Schroeder ThiloDirS - Sale$30.41-70,8281,124,974-6%-$2,154,007
D
2021-09-10
OLMAOlema Pharmaceuticals, Inc.Horn KinneyChief Business OfficerS - Sale+OE$29.38-5,2511,790-75%-$154,274
2021-09-10
ALXOAlx Oncology Holdings IncRandolph SophiaChief Medical OfficerS - Sale$77.66-7,387156,815-4%-$573,670
DM
2021-09-09
MORFMorphic Holding, Inc.Rogers BruceChief Scientific OfficerS - Sale+OE$62.00-40,00089,905-31%-$2,480,045
2021-09-09
EMMAEmmaus Life Sciences, Inc.Niihara YutakaCOB, CEO, 10%P - Purchase$1.67+2,50011,028,8590%+$4,175
2021-09-13
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.04-20,00024,258,5460%-$20,800
2021-09-13
EYENEyenovia, Inc.Rowe Michael MCOOP - Purchase$4.40+1,5004,300+54%+$6,600
D
2021-09-09
VNDAVanda Pharmaceuticals Inc.Mitchell Stephen RayDirS - Sale+OE$16.74-19,1099,215-67%-$319,976
D
2021-09-09
MYOVMyovant Sciences Ltd.Curran TerrieDirS - Sale+OE$25.58-4,8500-100%-$124,063
2021-09-10
OPNTOpiant Pharmaceuticals, Inc.Collard Craig ADirP - Purchase$18.18+9,57713,577+239%+$174,110
D
2021-09-10
NRIXNurix Therapeutics, Inc.Ring ChristineGCS - Sale+OE$35.93-2,0001,286-61%-$71,860
D
2021-09-10
REGNRegeneron Pharmaceuticals, Inc.Goldstein Joseph LDirS - Sale+OE$650.00-2,4795,891-30%-$1,611,350
D
2021-09-10
RAPTRapt Therapeutics, Inc.Brockstedt Dirk G.Chief Scientific OfficerS - Sale+OE$35.78-2,64819,812-12%-$94,745
M
2021-09-09
IMNMImmunome Inc.Rapp MichaelDirP - Purchase$18.07+45,950982,646+5%+$830,449
2021-09-02
BAMMBody & Mind Inc.Australis Capital Inc10%S - Sale$0.24-5,900,0008,206,549-42%-$1,398,890
2021-09-09
GBTGlobal Blood Therapeutics, Inc.Morrison Scott WDirS - Sale$30.21-4,8003,037-61%-$145,003
M
2021-09-08
EMMAEmmaus Life Sciences, Inc.Lee Willis CVice COB, COOP - Purchase$1.71+4,000368,335+1%+$6,840
D
2021-09-08
ABTAbbott LaboratoriesPederson Michael JSVPS - Sale+OE$129.05-23,00862,646-27%-$2,969,173
DM
2021-09-08
NKTRNektar TherapeuticsChess RobertDirS - Sale+OE$16.01-18,279280,573-6%-$292,670
M
2021-09-08
PGENPrecigen, Inc.Ares Trading S.A.10%S - Sale$6.31-90,62121,103,2900%-$571,402
A
2021-08-19
HCWBHcw Biologics Inc.Byam RebeccaCFOP - Purchase$4.40+10,00062,000+19%+$43,979
M
2021-08-02
CPIXCumberland Pharmaceuticals IncKazimi A JCOB, CEO, 10%P - Purchase$2.98+3155,769,1440%+$938
M
2021-07-01
CPIXCumberland Pharmaceuticals IncKazimi A JCOB, CEO, 10%P - Purchase$3.27+3155,768,8290%+$1,029
2021-09-09
SPROSpero Therapeutics, Inc.Aquilo Capital Management, LLC10%P - Purchase$18.50+24,7494,382,779+1%+$457,792
M
2021-05-28
CPIXCumberland Pharmaceuticals IncKazimi A JCOB, CEO, 10%P - Purchase$3.04+3455,768,5140%+$1,049
M
2021-04-16
CPIXCumberland Pharmaceuticals IncKazimi A JCOB, CEO, 10%P - Purchase$2.88+4505,768,1690%+$1,295
M
2021-08-02
CPIXCumberland Pharmaceuticals IncYoung CarolineDirP - Purchase$2.98+31513,358+2%+$938
M
2021-07-01
CPIXCumberland Pharmaceuticals IncYoung CarolineDirP - Purchase$3.27+31513,043+2%+$1,029
M
2021-05-28
CPIXCumberland Pharmaceuticals IncYoung CarolineDirP - Purchase$3.04+34512,728+3%+$1,049
M
2021-04-16
CPIXCumberland Pharmaceuticals IncYoung CarolineDirP - Purchase$2.88+45012,383+4%+$1,295
M
2021-08-02
CPIXCumberland Pharmaceuticals IncGalante Joseph CDirP - Purchase$2.98+2,98237,813+9%+$8,881
M
2021-08-02
CPIXCumberland Pharmaceuticals IncJones JamesDirP - Purchase$2.98+88216,296+6%+$2,627
D
2021-09-09
PRTAProthena Corp Public Ltd CoKarp Carol D.Chief Regulatory OfficerS - Sale+OE$71.98-10,0000-100%-$719,847
M
2021-08-02
CPIXCumberland Pharmaceuticals IncKrogulski KennethDirP - Purchase$2.98+1,785175,570+1%+$5,316
M
2021-08-02
CPIXCumberland Pharmaceuticals IncCearnal Martin ESVP, Chief Commercial OfficerP - Purchase$2.98+2,205169,464+1%+$6,567
M
2021-09-08
MYOVMyovant Sciences Ltd.Sumitomo Chemical Co., Ltd.10%P - Purchase$25.60+58,90249,354,1800%+$1,507,811
DM
2021-09-08
KRTXKaruna Therapeutics, Inc.Ignelzi Troy A.CFOS - Sale+OE$117.39-10,00018,000-36%-$1,173,846
2021-09-08
LUMOLumos Pharma, Inc.McKew John C.Chief Scientific OfficerS - Sale$11.30-2,21431,012-7%-$25,018
2021-09-09
ARWRArrowhead Pharmaceuticals, Inc.Given Douglas BDirS - Sale$65.24-5,000136,243-4%-$326,200
D
2021-09-09
ZLABZai Lab LtdReinhart HaraldChief Medical OfficerS - Sale+OE$141.36-10,0000-100%-$1,413,621
D
2021-09-09
PMVPPmv Pharmaceuticals, Inc.Alland LeilaChief Medical OfficerS - Sale+OE$30.25-1000-100%-$3,025
2021-09-08
JAZZJazz Pharmaceuticals PlcLarkin FinbarSVP, Technical OperationsS - Sale$134.51-6316,5790%-$8,474
D
2021-09-07
HRMYHarmony Biosciences Holdings, Inc.Dierks JeffreyChief Commercial OfficerS - Sale+OE$37.00-5,0000-100%-$185,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top